Short answer
HEALTHEQUITY, INC. (HQY) filed an 8-K current report with the SEC on September 30, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Noémie Heuland appointed director, expanding Board to 11 members from 10.
HEALTHEQUITY, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Noémie Heuland appointed director, expanding Board to 11 members from 10
- Moody’s CFO joins Audit and Risk Committee and Cybersecurity and Technology Committee
- HealthEquity paid Moody’s subsidiaries approximately $146,519 in fiscal 2026
- Moody’s subsidiary payments expected to exceed $120,000 in fiscal 2027, creating related-party disclosure
- Standard non-employee director compensation and indemnification arrangements apply
Item 7.01 · Regulation FD Disclosure
- Press release announces Ms. Heuland’s appointment to HealthEquity’s Board
- Board addition may affect governance, oversight, and strategic decision-making
- Investors should review Exhibit 99.1 for Ms. Heuland’s background and appointment details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HEALTHEQUITY, INC. 8-K filings
Get the next HQY 8-K as it lands
Follow HQY for push alerts, or ask the research agent what this filing means.